从China供应商批发进口2-Deoxy-D-Glucose — FOB条款

2-Deoxy-D-glucose is a glucose analogue used in scientific research, supplied by Wuhan Yuan Cheng GongChuang Technology Co.Ltd from Wuhan, Hubei, China. The product is listed with a molecular formula of C6H12O5, a molecular weight of 164.1565, and a CAS Registry Number of 154-17-6. It is supplied with a stated assay purity of 99% and is packaged in 25kg drums.

This compound is known by several synonyms, including 2-deoxy-D-arabino-hexose and 2-deoxyhexopyranose. It is a research-grade chemical, often utilized in metabolic studies and as a glycolysis inhibitor. The listing indicates a price of $2500 per kilogram, though this should be confirmed directly with the supplier for current and bulk pricing. The material is classified under EINECS number 205-823-0.

Primary applications are in academic and pharmaceutical research laboratories studying cellular metabolism, glucose transport, and cancer cell biology. Buyers in this sector typically require certificates of analysis (CoA) and detailed material safety data sheets (MSDS). It is essential to confirm the exact grade, batch-specific documentation, and export licensing requirements with Wuhan Yuan Cheng GongChuang Technology Co.Ltd prior to procurement, as regulatory controls for research chemicals can be stringent.

Wuhan Yuan Cheng GongChuang Technology Co.Ltd is based in Qianjiajie, Wuhan, Hubei Province, China, with postal code 432000. The supplier is listed under a 'harbor' trust tier, suggesting platform verification. However, the profile shows a 0.00% response rate and 0 average response hours, which is a critical point for buyers to consider when evaluating communication reliability.

The company's listing focuses on the supply of 2-deoxy-d-glucose, a specific biochemical research compound. The provided information is limited to the product's chemical specifications and does not include details about the company's operational history, quality management certifications (like ISO), or its client base in the research or pharmaceutical sectors. Buyers must independently verify the supplier's legitimacy and capability through direct inquiry and request relevant quality documentation.